Effects of purified eicosapentaenoic acid versus mixed eicosapentaenoic/docosahexaenoic acid pharmacotherapies on coronary plaque volume: network meta-analysis of prospective coronary imaging trials

By afschroeder • August 13, 2025

Sheppard JP, Lakshmanan S, Palatnic L, Dahal S, Roy SK, Bhatt DL, Budoff MJ, Nelson JR. Effects of purified eicosapentaenoic acid versus mixed eicosapentaenoic/docosahexaenoic acid pharmacotherapies on coronary plaque volume: network meta-analysis of prospective coronary imaging trials. Acta Cardiol. 2025 Aug 12:1-13. doi: 10.1080/00015385.2025.2538404. Epub ahead of print. PMID: 40795199.

Tags: Cardiology/Epi, coronary artery disease, coronary imaging, docosahexaenoic acid, Eicosapentaenoic acid, Harbor UCLA, meta-analysis, Omega-3 fatty acids, Publications

Waitlist mortality and post transplant survival amongst non-extracorporeal membrane oxygenation high-urgency heart transplant recipients before and after the 2018 policy change

White JP, Song J, Kim ST, Zappacosta H, Cho PD, McKay S, Girish A, Abramov A, Daniel M, Telesca D, Husain M, Ardehali A. Waitlist[...]

Evaluating the 2023 safety-net kidney policy: Eligibility and outcomes of heart transplant recipients in the United States

Zappacosta H, Daniel M, Tan N, Cho PD, Song J, White JP, Ardehali A. Evaluating the 2023 safety-net kidney policy: Eligibility and outcomes of heart[...]

Prediction of All-Cause Mortality, Cardiovascular Mortality, and Angiographic Coronary Disease From LVEF Reserve: Findings From the Multicenter REFINE PET Registry

Hijazi W, Zhou J, Miller RJH, Ramirez G, Lemley M, Shanbhag A, Kwiecinski J, Kavanagh PB, Parekh T, Liang JX, Alexanderson E, Carvajal-Juarez I, Slipczuk[...]